Binaytara Foundation Fellow & Resident Abstract Award Winners for 2022 Summit on Cancer Health Disparities Announced

Seattle, WA, April 6, 2022 – The Binaytara Foundation, a non-profit organization that works to improve equity in cancer care, has announced three Fellow & Resident Abstract Award winners for the 2022 Summit on Cancer Health Disparities (April 29 – May 1). This year’s recipients are:

·        Dr. Gladys M. Rodriguez from Stanford University for her abstract, “Addressing Latinx CANcer Care Equity (ALCANCE) Randomized Controlled Trial: Baseline Findings from a Community Health Worker-Led Intervention.” 

·        Dr. Utsav Joshi, a resident at Rochester General Hospital, for his abstract, “Factors Affecting Utilization of Chemotherapy in Acute Lymphoblastic Leukemia (ALL): A SEER Database Study.”

·        Dr. Pravash Budhathoki, a resident at Bronx-Lebanon Hospital Center, for his abstract, “Disparities in Breast Cancer Genomic Signature Ordering Practices in the United States.”

     “We would like to congratulate all three winners on their accomplishments,” says Binaytara Foundation president Dr. Binay Shah. “Their research has contributed to our knowledge of disparities in cancer care, which helps with our mission to reduce inequity and improve access to cancer treatment.”

Abstracts will be presented at the 2022 Summit on Cancer Health Disparities, which will be held from April 29th to May 1st, 2022 at the Grand Hyatt in Seattle. Two abstract sessions will be held on May 1st. Please click here to register for the summit.

The 2022 Summit on Cancer Health Disparities will bring together oncology professionals, cancer disparity researchers, and other stakeholders to discuss the factors leading to cancer health inequities. Additionally, they will explore ways to overcome the impact of these factors to optimize outcomes of cancer patients.

About Binaytara Foundation:

Binaytara Foundation is a global cancer non-profit dedicated to improving access to cancer care in the United States and abroad through education and innovative program models that break down barriers and advance best practices in hematology and oncology. Binaytara Foundation’s major projects include hematology and oncology conferences, and the establishment of a cancer hospital in Nepal.

Staff Writer - The Cancer News

Recent Posts

ADRIATIC: durvalumab (D) as consolidation treatment (tx) for patients (pts) with limited-stage small-cell lung cancer (LS-SCLC)

By: Tiantian Zhang1, Yiqun Han2, Lei Deng3 1. Department of Internal Medicine, University of Central…

3 months ago

ASCO24 LAURA Trial Summary

By: Zhiting Tang1, Lei Deng21. Unity Hospital, Rochester Regional Health, Rochester, NY2. University of Washington/Fred…

3 months ago

FDA Approves Tovorafenib for Pediatric Low-Grade Glioma With BRAF Mutation

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 23, 2024, the U.S. Food and Drug…

4 months ago

FDA Approves Tisotumab Vedotin for Recurrent or Metastatic Cervical Cancer

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 29, 2024, the U.S. Food and Drug…

4 months ago

FDA Approves Lutetium Lu 177 Dotatate for SSTR-Positive Gastroenteropancreatic Neuroendocrine Tumors

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 23, 2024, the U.S. Food and Drug…

4 months ago

FDA Approves Alectinib for Adjuvant Treatment in Non-Small Cell Lung Cancer

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 18, 2024, the U.S. Food and Drug…

4 months ago